N/A
Completed N=91
Preoxygenation Using THRIVE Versus Facemask in Parturients
Preoxygenation
Source: ClinicalTrials.gov NCT03772574 ↗
Enrolled (actual)
91
Serious AEs
0.0%
Results posted
May 2022
Primary outcomePrimary: Preoxygenation Duration — 3.6; NA; NA minutes
Summary
This study aims to determine the duration for pre-oxygenation using THRIVE and facemask for parturients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Preoxygenation Duration |
3.6; NA; NA | — |
| SECONDARY Proportion to Reach End Tidal Oxygen (ETO2) of 90 Percent at 3 Minutes |
10; 0; 0 | — |
| SECONDARY Proportion to Reach EtO2 of 90 Percent at 4 Minutes |
26; 2; 4 | — |
| SECONDARY Proportion to Reach EtO2 of 90 Percent at 5 Minutes |
0; 0; 0 | — |
| SECONDARY Proportion to Reach EtO2 of 90 Percent at 6 Minutes |
0; 0 | — |
| SECONDARY Proportion to Reach EtO2 of 90 Percent at 7 Minutes |
0; 0; 0 | — |
| SECONDARY Proportion to Reach EtO2 of 90 Percent at 8 Minutes |
0; 1; 5 | — |
| SECONDARY Comfort Score |
4; 4; 4 | — |
| SECONDARY Acceptability Score |
5; 4.5; 5 | — |
Eligibility Criteria
Inclusion Criteria
- Pregnant patients ≥36 weeks gestation.
- Non-laboring patients admitted for elective Cesarean delivery under neuraxial anesthesia or induction of labor.
- American Society of Anesthesiologists (ASA) class 2.
Exclusion Criteria
- Any medical conditions that are likely to affect gas exchange.
- Obstructed nasal passage.
- Unable to tolerate a tight fitting facemask.
- Body Mass Index ≥40 kg/m2.
- Patients who are in active labor (i.e. cervical dilation ≥4cm).
- Patients who are unable to give informed consent.
Data sourced from ClinicalTrials.gov (NCT03772574). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.